Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Eli Lilly 22.974, Amgen 10.054.
Eli Lilly vs Amgen: Revenue Comparison
Eli Lilly (LLY) and Amgen (AMGN) are peers in GLP-1. Eli Lilly reported revenue of $23.0B as of Q2 2026, compared with $10.1B for Amgen. Eli Lilly leads on revenue.
Eli Lilly's gross margin is 85.8% versus 72.0% for Amgen. Eli Lilly's net margin is 30.9% versus 23.6% for Amgen.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Eli Lilly, Amgen.| Metric | Eli Lilly | Amgen |
|---|---|---|
| Market Cap | - | - |
| Revenue | $22.97B | $10.05B |
| Cost of Revenue | $3.27B | $2.81B |
| Gross Profit | $19.71B | $7.24B |
| Operating Income | $8.98B | $3.51B |
| Net Income | $7.09B | $2.38B |
| R&D Expense | $3.82B | $1.87B |
| Earnings Per Share | $7.94 | $4.37 |
| Gross Margin | 85.8% | 72.0% |
| Operating Margin | 39.1% | 35.0% |
| Net Profit Margin | 30.9% | 23.6% |
| Free Cash Flow | $7.76B | $3.49B |
| Cumulative Free Cash Flow | $109.66B | $169.18B |
| Operating Cash Flow | $10.69B | $4.00B |
| Cash & Equivalents | $8.89B | $13.99B |